Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Virtual Patient Steering Committee: A Customer Story

A French pharmaceutical team contacted Impetus Digital to help them establish a Virtual Steering Committee for patients with HIV/AIDS. They wanted to find a way to directly involve patients in...

Impetus Digital

Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?

In this article we explore what more could be done by the pharmaceutical industry to help prevent the spread of HIV infection worldwide.

Inizio

- PMLiVE

Webcast: China Update 2023: How will recent developments impact your brand’s success?

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

Inizio

- PMLiVE

AstraZeneca’s heart failure treatment approved for expanded use in US

Chronic heart failure is the leading cause of hospitalisation for those over the age of 65

- PMLiVE

GSK’s RSV vaccine approved by FDA for older adults

Arexvy is the first RSV vaccine for this age group to be approved anywhere in the world

- PMLiVE

Positive results for Sanofi/Regeneron’s Dupixent published in Nature Medicine

The biologic was shown to significantly improve uncontrolled prurigo nodularis symptoms

- PMLiVE

CureVac announces start of phase 1/2 seasonal influenza vaccine trial

The multivalent mRNA candidates have been developed in collaboration with GSK

- PMLiVE

Role of pharmacists widened under England’s new GP recovery plan

The plan is expected to free up around 15 million GP appointments over the next two years

- PMLiVE

WHO declares end to COVID-19 global public health emergency

The agency’s emergency committee said it is time to transition to long-term management of the pandemic

Origins’ Solutions Offering Explained

Providing patient solutions that are wanted, needed, accessible, and fit for purpose can help companies to increase the value and success of their products and gain respect and recognition for...

Origins – The Patient Focused Specialists

Leveraging virtual tools to get the most out of hybrid congresses

Tips on how to optimize congress information-gathering...

Impetus Digital

- PMLiVE

Eli Lilly’s Alzheimer’s drug shown to significantly slow disease progression in phase 3 trial

Donanemab slowed the progression of early Alzheimer’s disease by 35% compared to placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links